Transmissible spongiform encephalopathy Microchapters |
Differentiating Transmissible spongiform encephalopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transmissible spongiform encephalopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Transmissible spongiform encephalopathy epidemiology and demographics |
FDA on Transmissible spongiform encephalopathy epidemiology and demographics |
CDC on Transmissible spongiform encephalopathy epidemiology and demographics |
Transmissible spongiform encephalopathy epidemiology and demographics in the news |
Blogs on Transmissible spongiform encephalopathy epidemiology and demographics |
Directions to Hospitals Treating Transmissible spongiform encephalopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
These spontaneous disorders in humans are very rare affecting only about one person per million worldwide each year.
However, transmissible TSEs can reach epidemic proportions as was seen in the UK BSE outbreak of the 80s and 90s. It is very hard to map the spread of the disease due to the difficulty of identifying individual strains of the prions. This means that if animals start to show the disease after an outbreak on a nearby farm then you cannot show that it is the same strain affecting both, suggesting transmission, or that the second outbreak came from a completely different source.